What is the frequency of congenital hydrocephalus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Frequency of Congenital Hydrocephalus

The incidence of congenital hydrocephalus is approximately 0.2 per 1,000 live births in the United States, though global estimates range from 0.1-0.6% of live births (1-6 per 1,000 births) depending on geographic region and socioeconomic factors. 1, 2

Geographic and Demographic Variations

United States and Developed Countries

  • The current birth prevalence in the United States is approximately 0.2 per 1,000 live births, representing a decline over recent decades largely due to periconceptional folate supplementation 1
  • In developed countries, the incidence of neonatal hydrocephalus ranges from 3 to 5 cases per 1,000 live births 3
  • The pediatric hydrocephalus incidence rate is approximately 0.1-0.6% of live births, making it as common as Down syndrome in infants 2

Ethnic Variations in the United States

  • Hispanic infants have the highest prevalence at 1.12 per 1,000 live births 1
  • African American and Asian infants have the lowest prevalence at 0.75 per 1,000 live births 1
  • Non-Hispanic white infants have intermediate rates at 0.96 per 1,000 live births 1

International Variations

  • Continental European countries show incidence varying between 1 in 1,700 to 1 in 10,000 live births 1
  • The British Isles demonstrate higher rates, varying from 1 in 260 to 1 in 400 live births 1
  • Ireland has the highest rate in Europe at 1 in 200 live births 1

Etiology-Specific Frequencies

Myelomeningocele-Associated Hydrocephalus

  • Myelomeningocele (MMC) is the most common dysraphic malformation compatible with life and represents the archetype of neural tube defects 1
  • Hydrocephalus occurs in 70% of patients with myelomeningocele 1, 4
  • Chiari type II malformation is present in 98% of MMC cases 1, 4
  • The approximate incidence of myelomeningocele in the United States is 3.4 per 10,000 live births 1

Fetal Aqueductal Stenosis

  • Fetal aqueductal stenosis is one of the most common causes of congenital hydrocephalus 5
  • Approximately 2-4 infants per 10,000 births develop aqueductal stenosis leading to progressive hydrocephalus 5
  • Historical data indicates congenital hydrocephalus occurs in about 1 in every 1,000 live births 6

Regional Burden in Resource-Limited Settings

African Context

  • In Africa, best current estimates suggest the incidence of congenital and acquired infant hydrocephalus may be between 80 and 125 cases per 100,000 births 7
  • In Mozambique, using developed country data, the expected incidence of neonatal hydrocephalus would range from 2,900 to 4,800 cases per year 3
  • The pooled proportion of non-postinfectious (congenital and acquired) hydrocephalus in Africa is 21% 1
  • Spinal dysraphism accounts for 16% of pediatric hydrocephalus cases across Africa 1

Asian Context

  • The pooled proportion of postinfectious hydrocephalus in Asia is 10.7%, suggesting a lower burden of acquired causes compared to Africa 1

Important Clinical Considerations

Diagnostic Challenges

  • Congenital hydrocephalus can be diagnosed by ultrasound as early as 20 weeks of gestation 6
  • In resource-limited settings, significant underdiagnosis occurs, with identified cases being considerably lower than expected incidence 3
  • Many cases present with severe macrocephaly and classic stigmata by the time of diagnosis, particularly in areas with limited prenatal screening 3

Burden of Disease

  • The prevalence (total burden) of hydrocephalus is expected to increase due to improved survival rates with prompt diagnosis and treatment 7
  • Most babies born with aqueductal stenosis are severely neurologically impaired and experience lifelong disability 5
  • High rates of follow-up loss (44.3%) occur in resource-limited settings, particularly among children from distant locations 3

Prevention Impact

  • The incidence of neural tube defects has been declining over recent decades, primarily due to periconceptional folate supplementation 1
  • Provision of folic acid for all women of childbearing age is critical, as roughly 80% of children with spina bifida develop hydrocephalus 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hydrocephalus: historical analysis and considerations for treatment.

European journal of medical research, 2022

Guideline

Malformación de Chiari Tipo 2: Definición y Complicaciones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Insights into the epidemiology of infant hydrocephalus.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.